Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	IPO	Common Stock	Common Stock IPO	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital IPO	Accumulated Other Comprehen-sive Loss	Accumulated Deficit
Convertible preferred stock outstanding at beginning of period (in shares) at Dec. 31, 2018	40,750,324
Convertible preferred stock outstanding at beginning of period at Dec. 31, 2018	$ 123,264
Convertible preferred stock outstanding at end of period (in shares) at Dec. 31, 2019	40,750,324
Convertible preferred stock outstanding at end of period at Dec. 31, 2019	$ 123,264
Total stockholders’ equity (deficit) at beginning of period (in shares) at Dec. 31, 2018			37,958,143		(1,968,228)
Total stockholders’ equity (deficit) at beginning of period at Dec. 31, 2018	(56,864)		$ 1		$ (4,598)	$ 30,863		$ (53)	$ (83,077)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock option plan (in shares)			3,137,706
Issuance of common stock under stock option plan	5,819					5,819
Stock-based compensation	19,214					19,214
Other comprehensive loss	(59)							(59)
Net loss attributable to common stockholders	(40,390)								(40,390)
Total stockholders’ equity (deficit) at the end of the period (in shares) at Dec. 31, 2019			41,095,849		(1,968,228)
Total stockholders’ equity (deficit) at end of period at Dec. 31, 2019	$ (72,280)		$ 1		$ (4,598)	55,896		(112)	(123,467)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock (in shares)	4,721,905
Issuance of convertible preferred stock	$ 49,810
Convertible preferred stock outstanding at end of period (in shares) at Dec. 31, 2020	45,472,229
Convertible preferred stock outstanding at end of period at Dec. 31, 2020	$ 173,074
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under stock option plan (in shares)			4,203,490
Issuance of common stock under stock option plan	13,905					13,905
Stock-based compensation	29,982					29,982
Other comprehensive loss	(133)							(133)
Net loss attributable to common stockholders	(43,568)								(43,568)
Total stockholders’ equity (deficit) at the end of the period (in shares) at Dec. 31, 2020			45,299,339		(1,968,228)
Total stockholders’ equity (deficit) at end of period at Dec. 31, 2020	$ (72,094)		$ 1		$ (4,598)	99,783		(245)	(167,035)
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to common stock in connection with initial public offering (in shares)	(45,472,229)
Conversion of convertible preferred stock to common stock in connection with initial public offering	$ (173,074)
Convertible preferred stock outstanding at end of period (in shares) at Dec. 31, 2021	0
Convertible preferred stock outstanding at end of period at Dec. 31, 2021	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs (in shares)				16,500,000
Issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs		$ 722,981		$ 1			$ 722,980
Issuance of common stock under stock option plan (in shares)			3,793,386
Issuance of common stock under stock option plan	15,502					15,502
Issuance of common stock under employee stock purchase plan, net of taxes withheld (ins hares)			117,996
Issuance of common stock under equity incentive plan, net of taxes withheld	4,401					4,401
Issuance of common stock for acquisition (in shares)			636,994
Issuance of common stock for acquisition	27,566					27,566
Exercise of common stock warrants (in shares)			296,848
Conversion of redeemable preferred stock warrants to common stock warrants	13,906					13,906
Conversion of convertible preferred stock to common stock in connection with initial public offering (in shares)				45,472,229
Conversion of convertible preferred stock to common stock in connection with initial public offering		$ 173,074					$ 173,074
Repurchase and retirement of common stock (in shares)			(2,940,929)
Repurchase and retirement of common stock	(350,000)					(350,000)
Stock-based compensation	62,493					62,493
Other comprehensive loss	(129)							(129)
Net loss attributable to common stockholders	(19,503)								(19,503)
Total stockholders’ equity (deficit) at the end of the period (in shares) at Dec. 31, 2021			109,175,863		(1,968,228)
Total stockholders’ equity (deficit) at end of period at Dec. 31, 2021	$ 578,197		$ 2		$ (4,598)	$ 769,705		$ (374)	$ (186,538)